{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:23:55Z","timestamp":1707524635565},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,5]]},"DOI":"10.7759\/cureus.29937","type":"journal-article","created":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T10:36:52Z","timestamp":1664966212000},"source":"Crossref","is-referenced-by-count":0,"title":["A Hypertrophic Spinal Pachymeningitis Patient With Factor V Leiden (G1691A), MTHFR C677T, MTHFR A1298C, PAI-1 4G-5G, Glycoprotein IIIa L33P Gene Mutations"],"prefix":"10.7759","author":[{"given":"Serkan","family":"Civlan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cemre","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duygu","family":"Herek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130brahim","family":"T\u00fcrk\u00e7\u00fcer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramazan","family":"Sabirli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aylin","family":"Koseler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.1001\/archneurpsyc.1949.02310160003001","article-title":"Chronic pachymeningitis; report of a case and review of the literature","volume":"62","author":"Naffziger HC","year":"1949","unstructured":"Naffziger HC, Stern WE. Chronic pachymeningitis; report of a case and review of the literature. Arch Neurol Psychiatry. 1949, 62:383-411.","journal-title":"Arch Neurol Psychiatry"},{"key":"ref2","article-title":"Deux cas d\u2019athrophie musculaire progressive avec l\u00e9sions de la substance gris et des faisceaux ant\u00e9riolat\u00e9raux de la melle \u00e9pini\u00e8re","volume":"2","author":"Charcot JM","year":"1869","unstructured":"Charcot JM, Joffroyn A. Deux cas d\u2019athrophie musculaire progressive avec l\u00e9sions de la substance gris et des faisceaux ant\u00e9riolat\u00e9raux de la melle \u00e9pini\u00e8re. Arch Physiol Norm Pathol. 1869, 2:354-67.","journal-title":"Arch Physiol Norm Pathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-007-0504-5","article-title":"Idiopathic hypertrophic cranial pachymeningitis treated by oral methotrexate: a case report and review of literature","volume":"28","author":"Bosman T","year":"2008","unstructured":"Bosman T, Simonin C, Launay D, Caron S, Dest\u00e9e A, Defebvre L. Idiopathic hypertrophic cranial pachymeningitis treated by oral methotrexate: a case report and review of literature. Rheumatol Int. 2008, 28:713-8. 10.1007\/s00296-007-0504-5","journal-title":"Rheumatol Int"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2013-306410","article-title":"A nationwide survey of hypertrophic pachymeningitis in Japan","volume":"85","author":"Yonekawa T","year":"2014","unstructured":"Yonekawa T, Murai H, Utsuki S, et al.. A nationwide survey of hypertrophic pachymeningitis in Japan. J Neurol Neurosurg Psychiatry. 2014, 85:732-9. 10.1136\/jnnp-2013-306410","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24222","article-title":"Factor V Leiden","volume":"91","author":"Van Cott EM","year":"2016","unstructured":"Van Cott EM, Khor B, Zehnder JL. Factor V Leiden. Am J Hematol. 2016, 91:46-9. 10.1002\/ajh.24222","journal-title":"Am J Hematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb05005.x","article-title":"High prevalence of a mutation in the factor V gene within the U.K. population: relationship to activated protein C resistance and familial thrombosis","volume":"88","author":"Beauchamp NJ","year":"1994","unstructured":"Beauchamp NJ, Daly ME, Hampton KK, Cooper PC, Preston FE, Peake IR. High prevalence of a mutation in the factor V gene within the U.K. population: relationship to activated protein C resistance and familial thrombosis. Br J Haematol. 1994, 88:219-22. 10.1111\/j.1365-2141.1994.tb05005.x","journal-title":"Br J Haematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V12102181","article-title":"The kidney and homocysteine metabolism","volume":"12","author":"Friedman AN","year":"2001","unstructured":"Friedman AN, Bostom AG, Selhub J, Levey AS, Rosenberg IH. The kidney and homocysteine metabolism. J Am Soc Nephrol. 2001, 12:2181-9. 10.1681\/ASN.V12102181","journal-title":"J Am Soc Nephrol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1055\/s-2000-8407","article-title":"Homocysteine and renal disease","volume":"26","author":"van Guldener C","year":"2000","unstructured":"van Guldener C, Robinson K. Homocysteine and renal disease. Semin Thromb Hemost. 2000, 26:313-24. 10.1055\/s-2000-8407","journal-title":"Semin Thromb Hemost"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V1161106","article-title":"Effect of high dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients: results of the Vienna multicenter study","volume":"11","author":"Sunder-Plassmann G","year":"2000","unstructured":"Sunder-Plassmann G, F\u00f6dinger M, Buchmayer H, et al.. Effect of high dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients: results of the Vienna multicenter study. J Am Soc Nephrol. 2000, 11:1106-16. 10.1681\/ASN.V1161106","journal-title":"J Am Soc Nephrol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2165\/00129785-200505020-00002","article-title":"Platelet glycoprotein IIb\/IIIa polymorphism and coronary artery disease: implications for clinical practice","volume":"5","author":"Di Castelnuovo A","year":"2005","unstructured":"Di Castelnuovo A, de Gaetano G, Benedetta Donati M, Iacoviello L. Platelet glycoprotein IIb\/IIIa polymorphism and coronary artery disease: implications for clinical practice. Am J Pharmacogenomics. 2005, 5:93-9. 10.2165\/00129785-200505020-00002","journal-title":"Am J Pharmacogenomics"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.90.1.362","article-title":"Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells","volume":"90","author":"van Leeuwen RT","year":"1994","unstructured":"van Leeuwen RT, Kol A, Andreotti F, Kluft C, Maseri A, Sperti G. Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells. Circulation. 1994, 90:362-8. 10.1161\/01.cir.90.1.362","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1023\/B:THRO.0000024052.79415.62","article-title":"4G\/5G PAI-1 promoter polymorphism and acute-phase levels of PAI-1 following coronary bypass surgery: a prospective study","volume":"16","author":"Burzotta F","year":"2003","unstructured":"Burzotta F, Iacoviello L, Di Castelnuovo A, et al.. 4G\/5G PAI-1 promoter polymorphism and acute-phase levels of PAI-1 following coronary bypass surgery: a prospective study. J Thromb Thrombolysis. 2003, 16:149-54. 10.1023\/B:THRO.0000024052.79415.62","journal-title":"J Thromb Thrombolysis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/114353-a-hypertrophic-spinal-pachymeningitis-patient-with-factor-v-leiden-g1691a-mthfr-c677t-mthfr-a1298c-pai-1-4g-5g-glycoprotein-iiia-l33p-gene-mutations","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:41:00Z","timestamp":1707507660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/114353-a-hypertrophic-spinal-pachymeningitis-patient-with-factor-v-leiden-g1691a-mthfr-c677t-mthfr-a1298c-pai-1-4g-5g-glycoprotein-iiia-l33p-gene-mutations"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,5]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.29937","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,5]]}}}